Seung-Hui Lee

Title: Seung-Hui Lee: Innovator in Erythropoietin Purification

Introduction

Seung-Hui Lee is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of erythropoietin analogs. His innovative methods have the potential to enhance the efficiency and cost-effectiveness of producing these important therapeutic proteins.

Latest Patents

Seung-Hui Lee holds a patent titled "Methods for purifying erythropoietin analogs having lower isoelectric point." This invention relates to a method for purifying an erythropoietin analog with a low isoelectric point below 4. The process involves adding an N-linked sugar chain with high purity. The method allows for effective purification of the erythropoietin analog, which has more sialic acid residues, through three-step chromatographic processes. This innovation is notable for its ability to achieve purification in a shorter time and at a lower cost.

Career Highlights

Seung-Hui Lee is associated with Chong Kun Dang Pharmaceutical Corporation, where he applies his expertise in biopharmaceutical development. His work focuses on improving the production processes of therapeutic proteins, which are crucial for treating various medical conditions.

Collaborations

Some of his notable coworkers include Yeo-Wook Koh and Sang-Yong Lee. Their collaborative efforts contribute to advancements in the field of biopharmaceuticals.

Conclusion

Seung-Hui Lee's innovative methods for purifying erythropoietin analogs represent a significant advancement in biopharmaceutical technology. His contributions are poised to make a lasting impact on the efficiency of therapeutic protein production.